ACE inhibitors after bypass surgery
Drugs known as angiotensin-converting enzyme (ACE) inhibitors can make all the difference in the world to length and quality of life for some people with heart disease and high blood pressure, one of the risk factors for heart disease. ACE inhibitors work by blocking hormones that regulate blood vessel constriction. This can reduce damage to the heart and kidneys in many ways—for example, by slowing deterioration of the heart muscle that occurs over time following a heart attack or deterioration of the kidneys in people with diabetes and kidney disease. The first ACE inhibitor, captopril (Capoten), was approved by the FDA in 1981 to lower blood pressure. Nine more are available today (see box).
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
